Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Dydrogesterone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR known ✓ | P06401 | 4/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 5/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 2/20 | 1.00 |
| ▸ | AR | P10275 | 2/20 | 1.00 |
| ▸ | CHRM1 | P11229 | 2/20 | 1.00 |
| ▸ | ADRA1A | P35348 | 2/20 | 1.00 |
| ▸ | TBXA2R | P21731 | 1/20 | 1.00 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.63 |
| ▸ | SERPINA6 | P08185 | 4/20 | 0.59 |
| ▸ | LMNA | P02545 | 3/20 | 0.59 |
| ▸ | NR3C1 | P04150 | 3/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.59 |
| ▸ | TSHR | P16473 | 2/20 | 0.59 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dydrogesterone SCHEMBL29335245 | 1.00 | CYP3A4 (1.00) | CYP3A4PGRALDH1A1CYP2C19AR | |
| Dydrogesterone SCHEMBL606816 | 1.00 | CYP3A4 (1.00) | CYP3A4PGRALDH1A1CYP2C19AR | |
| Dydrogesterone SCHEMBL13907084 | 1.00 | CYP3A4 (1.00) | CYP3A4PGRALDH1A1CYP2C19AR | |
| Dydrogesterone SCHEMBL23383832 | 1.00 | CYP3A4 (1.00) | CYP3A4PGRALDH1A1CYP2C19AR | |
| Dydrogesterone SCHEMBL18814051 | 1.00 | CYP3A4 (1.00) | CYP3A4PGRALDH1A1CYP2C19AR | |
| Dydrogesterone SCHEMBL23360787 | 1.00 | CYP3A4 (1.00) | CYP3A4PGRALDH1A1CYP2C19AR | |
| Dydrogesterone SCHEMBL20281282 | 1.00 | CYP3A4 (1.00) | CYP3A4PGRALDH1A1CYP2C19AR | |
| Dydrogesterone SCHEMBL606817 | 1.00 | CYP3A4 (1.00) | CYP3A4PGRALDH1A1CYP2C19AR | |
| Dydrogesterone SCHEMBL11512798 | 1.00 | CYP3A4 (1.00) | CYP3A4PGRALDH1A1CYP2C19AR | |
| Dydrogesterone SCHEMBL23360802 | 0.98 | CYP3A4 (0.96) | CYP3A4PGRALDH1A1CYP2C19AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5332 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4440706-B1 | COMPOSITIONS FOR PROMOTING HAIR GROWTH | ESTETRA SRL (BE) | 2026-04-29 | — | — | EP | claimed |
| EP-4732021-A1 | A METHOD FOR THE DETERMINATION OF THE LIKELIHOOD OF GETTING PREGNANT BASED ON MEASURING THE STNFR1 LEVEL | Instytut Immunologii I Terapii Doswiadczalnej Im. Ludwika Hirszfelda Polskiej Akademii Nauk (PL) | 2026-04-29 | — | — | EP | claimed |
| US-20260090995-A1 | ORODISPERSIBLE DOSAGE UNIT CONTAINING AN ESTETROL COMPONENT | ESTETRA SRL (BE) | 2026-04-02 | — | — | US | claimed |
| EP-4650359-A1 | STEROID COMPOUND FOR TREATING CENTRAL NERVOUS SYSTEM DISEASE, METHOD FOR PREPARING SAME, AND USE AND PHARMACEUTICAL COMPOSITION THEREOF | Hunan Kyf Pharmaceutical. Co., Ltd. (CN) | 2025-11-19 | — | — | EP | claimed |
| US-12458651-B2 | Compounds and their uses for alleviating menopause-associated symptoms | ESTETRA SRL (BE) | 2025-11-04 | — | — | US | claimed |
| EP-4637777-A1 | USE OF ESTETROL IN HEPATICALLY IMPAIRED PATIENTS | Estetra SRL (BE) | 2025-10-29 | — | — | EP | claimed |
| US-12427114-B2 | Orodispersible dosage unit containing an estetrol component | ESTETRA SRL (BE) | 2025-09-30 | — | — | US | claimed |
| US-20250296950-A1 | INTERMEDIATE COMPOUND AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | HUNAN KYF PHARMACEUTICAL. CO., LTD. (CN) | 2025-09-25 | — | — | US | claimed |
| EP-4578442-A1 | MICROSPHERE COMPOSITION FOR CONTRACEPTIVE MICRONEEDLES AND CONTRACEPTIVE MICRONEEDLES COMPRISING THE SAME | Small'Lab Co., Ltd. (KR) | 2025-07-02 | — | — | EP | claimed |
| US-20250205250-A1 | MICROSPHERE COMPOSITION FOR CONTRACEPTIVE MICRONEEDLES AND CONTRACEPTIVE MICRONEEDLES COMPRISING THE SAME | SMALL'LAB CO., LTD. (KR) | 2025-06-26 | — | — | US | claimed |
| US-5211952-A | Drug delivery of gonadotropin hormone releasing hormones for time release | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 1993-05-18 | — | — | US | claimed |
| EP-0538443-A1 | METHODS AND FORMULATIONS FOR USE IN INHIBITING CONCEPTION AND IN TREATING BENIGN GYNECOLOGICAL DISORDERS. | UNIV SOUTHERN CALIFORNIA (US) | 1993-04-28 | — | — | EP | claimed |
| WO-1993000058-A1 | SOLUBILITY PARAMETER BASED DRUG DELIVERY SYSTEM AND METHOD FOR ALTERING DRUG SATURATION CONCENTRATION | NOVEN PHARMACEUTICALS, INC. (US) | 1993-01-07 | — | — | WO | claimed |
| WO-1992018107-A1 | METHODS AND FORMULATIONS FOR USE IN INHIBITING CONCEPTION AND IN TREATING BENIGN GYNECOLOGICAL DISORDERS | THE UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 1992-10-29 | — | — | WO | claimed |
| WO-1992015289-A1 | COMPOSITIONS AND METHODS FOR TOPICAL ADMINISTRATION OF PHARMACEUTICALLY ACTIVE AGENTS | NOVEN PHARMACEUTICALS, INC. (US) | 1992-09-17 | — | — | WO | claimed |
| CN-1041528-A | HORMONE PREPARATION AND METHOD | JENCAP RESEARCH LTD (CA) | 1990-04-25 | — | — | CN | claimed |
| US-4826831-A | Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens | PRE JAY HOLDINGS LIMITED (CA) | 1989-05-02 | — | — | US | claimed |
| EP-0309263-A2 | Hormone composition and use | JENCAP RESEARCH LIMITED (CA) | 1989-03-29 | — | — | EP | claimed |
| US-4054651-A | Method of contraception | RICHARDSON-MERRELL INC. (US) | 1977-10-18 | — | — | US | claimed |
| US-4014987-A | VAGINAL DEVICE; USING A HYDROPHOBIC POLYCARBOXYLIC ACID AS DRUG RELEASE RATE CONTROLLER | ALZA CORPORATION (US) | 1977-03-29 | — | — | US | claimed |